Cryo-Cell International Inc (CCEL) USD0.01
Cryo-Cell International, Inc. (Cryo-Cell) cord blood banking company. The Company/Cryo-Cell operates its own processing, testing and cryopreservation operation. The Company operates through three segments: cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use; manufacture of PrepaCyte CB units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company, in combination with its global affiliates, stores approximately 500,000 cord blood and cord tissue specimens worldwide for the benefit of new-born babies and other members of their families.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.